{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:16:09Z","timestamp":1788066969282,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772281"],"award-info":[{"award-number":["81772281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025LSW023"],"award-info":[{"award-number":["ZR2025LSW023"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024MH228"],"award-info":[{"award-number":["ZR2024MH228"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154381","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:08:16Z","timestamp":1785481696000},"page":"154381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibited proliferation and immune evasion of lung cancer: The key role of miR-4483 in lncRNA linc00824\/miR-4483\/PD-L1 pathway"],"prefix":"10.1016","volume":"832","author":[{"given":"Jia-Xiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ming","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangling","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8090-2180","authenticated-orcid":false,"given":"Shu-Yang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154381_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.154381_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semcancer.2022.08.002","article-title":"Artificial intelligence-based prediction of clinical outcome in immunotherapy and targeted therapy of lung cancer","volume":"86","author":"Yin","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2026.154381_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s40001-022-00835-4","article-title":"Tumor microenvironment and immunotherapy of oral cancer","volume":"27","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bbrc.2026.154381_bib4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","article-title":"Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment","volume":"43","author":"Apostolova","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbrc.2026.154381_bib5","article-title":"Lactate-lactylation hands between metabolic reprogramming and immunosuppression","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154381_bib6","article-title":"A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbrc.2026.154381_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216467","article-title":"Histone lactylation-derived LINC01127 promotes the self-renewal of glioblastoma stem cells via the cis-regulating the MAP4K4 to activate JNK pathway","volume":"579","author":"Li","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154381_bib8","article-title":"Lactate metabolism-associated lncRNA pairs: a prognostic signature to reveal the immunological landscape and mediate therapeutic response in patients with Colon adenocarcinoma","volume":"13","author":"Xiao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154381_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ije\/dyy262","article-title":"An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings","volume":"48","author":"Sanderson","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbrc.2026.154381_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.bbrc.2026.154381_bib11","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbrc.2026.154381_bib12","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/hmg\/ddm218","article-title":"Restoration of the balanced alpha\/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach","volume":"16","author":"Xie","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2026.154381_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s42003-024-05854-x","article-title":"m6A-methylated KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell autophagy through TIPR","volume":"7","author":"Liang","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2026.154381_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41420-022-01095-1","article-title":"Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession","volume":"8","author":"Liu","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbrc.2026.154381_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/15384047.2017.1281497","article-title":"MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals","volume":"18","author":"Lv","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbrc.2026.154381_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28247989","article-title":"Dimethyl bisphenolate ameliorates carbon tetrachloride-induced liver injury by regulating oxidative stress-related genes","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.154381_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1032850","article-title":"WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P\/miR-628\/SMAD3 axis","volume":"12","author":"Wei","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.154381_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2415389122","article-title":"EGFR-induced lncRNA TRIDENT promotes drug resistance in non-small cell lung cancer via phospho-TRIM28-mediated DNA damage repair","volume":"122","author":"Saxena","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbrc.2026.154381_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12967-025-06205-y","article-title":"RBM15 recruits myeloid-derived suppressor cells via the m6A-IGF2BP3\/CBR3-AS1\/miR-409-3p\/CXCL1 axis, facilitating radioresistance in non-small-cell lung cancer","volume":"23","author":"Hu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.154381_bib20","article-title":"No evidence of a genetic causal relationship between ankylosing spondylitis and Gut Microbiota: a two-sample Mendelian randomization study","volume":"15","author":"Yang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2026.154381_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.154381_bib22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41388-024-03243-6","article-title":"Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer","volume":"44","author":"Tsukihara","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154381_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6696","article-title":"Class I histone deacetylases (HDAC1-3) are histone lysine delactylases","volume":"8","author":"Moreno-Yruela","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2026.154381_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-05939-3","article-title":"Lactate regulates cell cycle by remodelling the anaphase promoting complex","volume":"616","author":"Liu","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154381_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.lungcan.2017.08.005","article-title":"PD-L1 expression in advanced NSCLC: insights into risk stratification and treatment selection from a systematic literature review","volume":"112","author":"Brody","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbrc.2026.154381_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jmii.2019.10.006","article-title":"Lactate up-regulates the expression of PD-L1 in kidney and causes immunosuppression in septic acute renal injury","volume":"54","author":"Xu","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.bbrc.2026.154381_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2026.154381_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/imm.13588","article-title":"CD8(+) T cell exhaustion in anti-tumour immunity: the new insights for cancer immunotherapy","volume":"168","author":"Huang","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.bbrc.2026.154381_bib29","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.154381_bib30","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1038\/s41467-023-43974-w","article-title":"LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation","author":"Zhu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154381_bib31","article-title":"Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: a multicohort, open-label, phase II trial with biomarker analysis","volume":"13","author":"Zhang","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2026.154381_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Martinez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154381_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216896","article-title":"Lactate and lactylation: behind the development of tumors","volume":"591","author":"Dai","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154381_bib34","doi-asserted-by":"crossref","first-page":"E330","DOI":"10.1152\/ajpendo.00159.2022","article-title":"Lactylation: novel epigenetic regulatory and therapeutic opportunities","volume":"324","author":"Fan","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2026.154381_bib35","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1158\/0008-5472.CAN-21-0914","article-title":"Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer","volume":"82","author":"Ippolito","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154381_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2421496121","article-title":"DPF2 reads histone lactylation to drive transcription and tumorigenesis","volume":"121","author":"Zhai","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154381_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12943-023-01814-x","article-title":"LINC02159 promotes non-small cell lung cancer progression via ALYREF\/YAP1 signaling","volume":"22","author":"Yang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.154381_bib38","article-title":"A novel cancer-associated lncRNA, LINC01123, participates in tumor progression, metabolism, immune escape, and resistance","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154381_bib39","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1158\/0008-5472.CAN-22-1289","article-title":"MNX1-AS1 promotes phase separation of IGF2BP1 to drive c-Myc-Mediated cell-cycle progression and proliferation in lung cancer","volume":"82","author":"Zhu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154381_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mco2.49","article-title":"The multifaceted involvement of exosomes in tumor progression: induction and inhibition","volume":"2","author":"Gu","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.bbrc.2026.154381_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071587","article-title":"miRNAs and lncRNAs as novel therapeutic targets to improve cancer immunotherapy","volume":"13","author":"Di Martino","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.154381_bib42","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.7150\/jca.83466","article-title":"LncRNA LINC01569 promotes M2 macrophage polarization to accelerate hypopharyngeal carcinoma progression through the miR-193a-5p\/FADS1 signaling axis","volume":"14","author":"Gong","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154381_bib43","article-title":"Qntrolling the LncRNA HULC-Tregs-PD-1 axis inhibits immune escape in the tumor microenvironment","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2026.154381_bib44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s40001-023-01309-x","article-title":"Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance","volume":"28","author":"Qin","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bbrc.2026.154381_bib45","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1634\/theoncologist.2019-IO-S1-s05","article-title":"PD-1\/PD-L1 blockade therapy in advanced non-small-cell lung cancer: current status and future directions","volume":"24","author":"Xia","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.bbrc.2026.154381_bib46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.154381_bib47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12964-024-01711-w","article-title":"Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance","volume":"22","author":"Yang","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrc.2026.154381_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-024-01581-2","article-title":"Dual blockade immunotherapy targeting PD-1\/PD-L1 and CTLA-4 in lung cancer","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154381_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12865-024-00651-x","article-title":"beta-glucan combined with envafolimab and endostar as immune rechallenge for metastatic non-small cell lung cancer","volume":"25","author":"Geng","year":"2024","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bbrc.2026.154381_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00384-025-04806-z","article-title":"The efficacy and safety of suvemcitug, envafolimab, and FOLFIRI in microsatellite-stable or mismatch repair-proficient colorectal cancer: preliminary results of a phase 2 study","volume":"40","author":"Liu","year":"2025","journal-title":"Int. J. Colorectal Dis."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T04:22:38Z","timestamp":1788063758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26011459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S0006291X26011459"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154381","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibited proliferation and immune evasion of lung cancer: The key role of miR-4483 in lncRNA linc00824\/miR-4483\/PD-L1 pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154381"}}